"The success of antidepressant drug therapy is not high, with studies suggesting 19-60% of patients are unresponsive to the treatment". Optimal methylation seems to be one very important piece of the mood puzzle.
Belinda expertly navigates the complex nature of patient care for Methylation Disorders, MTHFR and Pyroluria.
Pyroluria is an emerging consideration in the treatment of mood disorders. In this podcast, Dr Mark Donohoe explores the integrative therapists approach.
Methylation is now a major focus for many health care practitioners. In each of us, this process occurs trillions of times every second and is involved in countless biochemical pathways. Efficient methylation is therefore essential to quality of life.
But, is our approach to methylation disorders appropriate?
According to Dr Mark Donohoe there is a tendency for practitioners to treat methylation issues with a sledge hammer and to approach this as if everybody needs treatment.